References
- Basma, A.N., Morris, E.J., Nicklas, W.J., and Geller, H.M., L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem., 64, 825-832 (1995) https://doi.org/10.1046/j.1471-4159.1995.64020825.x
- Desole, M.S., Sciola, L., Delogu, M.R., Siricana, R., and Migheli, R., Manganese and 1-methyl-4-(2'-ethylpheyl)-1,2,3,6-tetrahy-dropyridine induce apoptosis in PC12 cells. Neurosci., 209, 193-196 (1996) https://doi.org/10.1016/0304-3940(96)12645-8
- Graham, D.C., Tiffany, S.M., Bell, W.R Jr., and Gutknecht, W.F., Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol., 14, 644-653 (1978)
- Greene, L.A. and Tischler, A.S., Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA, 73, 2424-2428 (1976) https://doi.org/10.1073/pnas.73.7.2424
-
Itano, Y., Kitamura, Y., and Nomure, Y., 1-Methyl-4-phenylpyridinium (MPP
$^+$ )-induced cell death in PC12 cells: inhibitory effects of several drugs. Neurochem. Int., 25, 419-424 (1994) https://doi.org/10.1016/0197-0186(94)90017-5 - Kikuchi, K., Nagatsu, Y., Makino, Y., Mashino, T., Ohta, S., and Hirobe, M., Metabolism and penetration through the blood-brain barrier of parkinsonism-related compounds: 1,2,3,4-tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline. Drug Metab. Dispos., 19, 257-262 (1991)
- Kim, S.H., Shin, J.S., Lee, J.J., Yin, S.Y., Kai, M., and Lee, M.K., Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells. Planta Med., 67, 609-613 (2001) https://doi.org/10.1055/s-2001-17356
- Kotake, Y., Tasaki, Y., Makino, Y., Ohta, S., and Hirobe, M., 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian brain. J. Neurochem., 65, 2633-2638 (1995) https://doi.org/10.1046/j.1471-4159.1995.65062633.x
- Lee, J.J., Kim, Y.M., Yin, S.Y., Park, H.D., Kang, M.H., Hong, J.T., and Lee, M.K. Tetrahydropapaveroline aggravates L-DOPA-induced neurotoxicity in PC12 cells. Biochem. Pharamacol., 66, 1787-1795 (2003) https://doi.org/10.1016/S0006-2952(03)00421-0
- Lee, M.K., Zhang, Y.H., Shin, J.S., and Lee, S.S., Inhibition of tyrosine hydroxylase by hydrastine. Med. Sci. Res., 25, 619-620 (1997)
- McNaught, K. St. P., Carrupt, P.A., Altmore, C., Cellamare, S., Carotti, A., Testa, B., Jenner, P., and Marsden, C.D., Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinsons disease. Biochem. Phannacol., 56, 921-933 (1998) https://doi.org/10.1016/S0006-2952(98)00142-7
- Makino, Y., Ohta, S., Tachikawa, O., and Hirobe, M., Presence of tetrahydroisoquinoline and l-methyl-tetrahydroisoquinoline in foods: compounds related to Parkinson's disease. Life Sci., 43, 373-378 (1988) https://doi.org/10.1016/0024-3205(88)90115-4
- Marsden, C.D., Parkinson's disease. J. Neurol. Neruosurg. Psychiatry., 57, 672-681 (1994)
- Maruyama, W., Abe, T., Tohgi, H., Dostert, P., and Naoi, M., A dopaminergic neurotoxin, (R)-N-methylsalsolinol increases in parkinsonian cerebrospinal fluid. Ann. Neurol., 40, 119-122 (1996) https://doi.org/10.1002/ana.410400120
- Mosman, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immun. Meth., 65, 55-63 (1983) https://doi.org/10.1016/0022-1759(83)90303-4
-
Nagatsu, T., and Hirata, Y., Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP
$^+$ ) and the structurally related compounds in vitro and in vivo. Eur. Neurol., 26 (Suppl 1), 11-15 (1997) - Ohta, S., Isoquinolines in Parkinson's disease. In: Storch, A., Collins, M.A., editors. Neurotoxic factors in Parkinson's disease and related disorders. New York Plenum Press, 3, 33-42 (2000)
- Perry, T.L., Yong, V.W., Ito, M., Foulks, J.D., Wall, R.A., Godin, D.V., and Clavier, R.M., Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically. J. Neurochem., 43, 990-993 (1984) https://doi.org/10.1111/j.1471-4159.1984.tb12834.x
- Przedborski, S., and Vila, M., MPTP: A review of its mechanisms of neurotoxicity. Clin. Neurosci. Res., 1, 407-418 (2001) https://doi.org/10.1016/S1566-2772(01)00019-6
- Rosenberg, P.A., Catecholamine toxicity in cerebral cortex in dissociated cell culture. J. Neurosci., 8, 2887-2894 (1988)
- Rossor, M.N., Watkins, J., Brown, M.J., Reid, J.L., and Dollery, C.T., Plasma levodopa, dopamine and therapeutic response following levodopa therapy of parkinsonian patients. Brain Res., 46, 385-392 (1980)
- Sandstrom, P.A., Mannie, M.D., and Buttke, T.H., Inhibition of activation-induced death in T cell hybridomas by thiol antioxidant: oxidative stress as a mediator of apoptosis. J. Leukocyte Biol., 55, 221-226 (1994) https://doi.org/10.1002/jlb.55.2.221
- Tasaki, Y., Makino, Y., Ohta, S., and Hirobe, M., 1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreased in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities. J. Neurochem., 57, 1940-1943 (1991) https://doi.org/10.1111/j.1471-4159.1991.tb06407.x